The latest installment in the Venom franchise, "Venom: The Last Dance," fell short of expectations at the box office over its opening weekend, bringing in $51 million according to studio estimates. This figure is significantly lower than the previous entries in the series, with the original film debuting at $80.2 million and its sequel opening at $90 million.
Despite the lower domestic performance, "Venom: The Last Dance" has shown promise internationally, raking in $124 million over the weekend, including a strong showing in China with $46 million. While the film's production budget was relatively modest at $120 million, reviews have been lackluster with a 36% freshness rating on Rotten Tomatoes and a franchise-low "B-" CinemaScore.
The underwhelming performance of "Venom: The Last Dance" is part of a larger trend in the superhero genre, with film consultant David A. Gross predicting that 2024 superhero films will gross around $2.25 billion worldwide. This marks a significant decline from previous years when superhero films dominated the box office, with 2018 seeing over $7 billion in global ticket sales.
In contrast to the superhero genre's struggles, the adult-oriented drama "Conclave" emerged as a surprise success over the weekend, bringing in $6.5 million and landing in third place at the box office. With strong reviews and a growing buzz as an Oscar contender, "Conclave" could continue to build momentum with audiences and awards voters.
Overall, the box office landscape remains in flux with shifting trends in genre popularity and audience preferences. While "Venom: The Last Dance" may have fallen short of expectations, the success of films like "Conclave" demonstrates that there is still room for diverse and engaging storytelling in the cinematic landscape.